H.E. Mubaraka Ibrahim, Chief Information Officer and Chief AI Officer at Emirates Health Services (EHS), inaugurated the IBD ...
Fecal eosinophil-derived neurotoxin, lipocalin-2, and calprotectin are elevated in pediatric IBD, with calprotectin best distinguishing IBD from acute diarrhea, a recent study shows.
The peptides being evaluated have been proposed to treat conditions including insomnia, ulcerative colitis, migraines and ...
Researchers at the Icahn School of Medicine at Mount Sinai have identified immune system changes that can be detected up to 10 years before inflammatory bowel disease (IBD) develops, offering new ...
Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the ...
A large South Korean cohort study has found no clear evidence that prenatal exposure to acid-suppressive medications ...
From groundbreaking robotic surgeries and advanced imaging technology to innovative women’s health treatments and AI-powered ...
Investor's Business Daily on MSN
Datadog, IBD stock of the day, breaks away from software pack
Datadog stock has surged as investors view its software as key in monitoring AI infrastructure while SaaS companies struggle.
ALPCO, a distributor of immunoassay-based products and part of NuvinkaDx announces H. pylori Stool Antigen and Lactoferrin assays have received Health Canada licenses, expanding the company’s menu of ...
After a 7% increase in revenue for the second quarter, which came on the heels of a 10% gain in Q1, Johnson & Johnson has bumped up its annual sales guidance. The company now projects 2026 revenue at ...
Abivax remains on track to submit the UC NDA during late Q4 2026, with Crohn’s Phase 2b top-line data anticipated mid-2027.
Health advisers begin meeting Thursday to review more than a half-dozen peptides, unproven substances that have become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results